RA Capital Healthcare Fund, Director: ARS Pharmaceuticals SPRY Buy · Filed 23/09/25

Trade details

Type: Insider buy
Amount: $7,450,812.27
Shares · price: 2,508,691 sh · $2.97 a share
Held after: 8,365,465 sh
Stock: ARS Pharmaceuticals SPRY
Person: RA Capital Healthcare FundDirector
Trade date: 23/09/21
Filed: 23/09/25
Days to filing: 4 days

6 insiders bought this week

Insiders buying this week: 6 insiders
Holding change: +42.8%

ARS Pharmaceuticals trades, last 26 weeks

What else happened in ARS Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/08/22~23/10/21

RA Capital Healthcare Fund's recent trades

RA Capital Healthcare FundDirector, 10% Stockholder
Planned saleSionna Therapeutics
Planned sale
Sionna Therapeutics
SION
$21.8M
3,448,811 sh
$21.8M
Filed 09/17
Traded 09/17
RA Capital Healthcare FundDirector
Planned saleSepterna
Planned sale
Septerna
SEPN
$36M
746,500 sh
$36M
Filed 08/12
Traded 08/12
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$275.3K
31,000 sh
$275.3K
Filed 06/29
Traded 06/25
RA Capital Healthcare FundDirector
BuyArtiva Biotherapeutics
Buy
Artiva Biotherapeutics
ARTV
$16.8K
1,876 sh
$16.8K
Filed 06/29
Traded 06/26
RA Capital Healthcare Fund10% Owner
SellWerewolf Therapeutics
Sell
Werewolf Therapeutics
HOWL
$136.2K
389,216 sh
$136.2K
Filed 06/22
Traded 06/17

RA Capital Healthcare Fund, Director — bought $7.5M of ARS Pharmaceuticals SPRY · 2,508,691 sh @ $2.97 | Whalegun